FLUVASTATIN Mepha caps 20 mg 100 pce

7680586710062 CH-58671 C10AA04 07.12.0.

Reimbursement limitations:

FLUVASTMEPHA

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

FLUVASTATIN Mepha caps 20 mg 100 pce
FLUVASTATIN Mepha caps 20 mg 100 pce
FLUVASTATIN Mepha caps 20 mg 100 pce
1 / 3
google

Details

Product number
5867101
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
fluvastatinum 20 mg ut fluvastatinum natricum 21.06 mg corresp. natrium 1.12 mg, lactosum monohydricum 99.591 mg, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Fluvastatin-Mepha 20 mg, Kapseln
Kapseln
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/11/2024
Patient information leaflet
Français
21/11/2024
Patient information leaflet
Italien
21/11/2024
Professional SmPC
Allemand
21/11/2024
Professional SmPC
Français
21/11/2024
Professional SmPC
Italien
21/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
21.06 MG Substance WIZUS
(N/A)
1.12 MG Substance HBESI
(N/A)
99.591 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 36.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2020

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
58671
Drug name
Fluvastatin-Mepha, Kapseln
Galenic form
KAHA
ATC Code
C10AA04
Authorization status
Z
Dispensation category
B
First authorization
14/10/2009
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration, primäre gemischte Dyslipidämie

Packaging details

Description (FR)
FLUVASTATIN Mepha caps 20 mg 100 pce
Description (DE)
FLUVASTATIN Mepha Kaps 20 mg 100 Stk
Market launch
14/10/2009
Narcotic (BTM)
No

Other packaging sizes

FLUVASTATIN Mepha caps 20 mg 30 pce
30 KAP
View
FLUVASTATIN Mepha caps 40 mg 30 pce
30 KAP
View
FLUVASTATIN Mepha caps 40 mg 100 pce
100 KAP
View